GENFIT (GNFT) Stock Chart & Stock Price History $3.75 +0.03 (+0.81%) As of 08/8/2025 03:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GENFIT Stock Price Performance The GENFIT (GNFT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 4.58%, with a year-to-date return of 1.08%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, GENFIT traded at $3.75 with a market cap of $187.50 million and volume of 16,482 shares. Five years ago, the stock traded at $5.13, representing a 26.90% decrease over that period. At the time, it had a market cap of $189.53 million and a volume of 58 shares. Receive GNFT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GENFIT and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.27%1 Month Performance0.00%3 Month Performance-12.79%Year-To-Date Performance+1.08%1 Year Performance-4.58%5 Year Performance-26.90% GNFT Stock Chart for Sunday, August, 10, 2025 GNFT Chart by TradingView GENFIT Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$3.81$3.75-1.57%$4.12$3.7116,482 shs$187.50 million08/07/2025$3.71$3.81+2.83%$3.96$3.734,077 shs$190.51 million08/06/2025$3.76$3.71-1.46%$3.84$3.81504 shs$185.25 million08/05/2025$3.79$3.76-0.79%$3.92$3.762,030 shs$188 million08/04/2025$3.82$3.79-0.66%$3.85$3.791,163 shs$189.51 million08/01/2025$3.84$3.82-0.52%$3.90$3.672,836 shs$190.75 million07/31/2025$3.90$3.84-1.54%$3.97$3.925,946 shs$191.76 million07/30/2025$4.01$3.90-2.87%$4.09$3.97875 shs$194.75 million07/29/2025$4.16$4.01-3.61%$4.19$4.01940 shs$200.50 million07/28/2025$3.88$4.16+7.35%$4.17$4.16522 shs$208.01 million Get the Latest News and Ratings for GNFT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GENFIT and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$4.06$3.88-4.56%$4.14$4.12758 shs$193.76 million07/24/2025$3.97$4.06+2.37%$4.20$3.943,532 shs$203 million07/23/2025$3.78$3.97+4.92%$4.07$4.0016,118 shs$198.30 million07/22/2025$3.86$3.78-2.07%$3.82$3.781,569 shs$189.01 million07/21/2025$3.82$3.86+1.18%$3.90$3.87667 shs$193 million07/18/2025$3.85$3.82-0.78%$3.93$3.79603 shs$190.75 million07/17/2025$3.87$3.85-0.62%$3.90$3.723,736 shs$192.25 million07/16/2025$3.78$3.87+2.25%$3.85$3.822,773 shs$193.46 million07/15/2025$3.79$3.78-0.16%$3.96$3.791,276 shs$189.20 million07/14/2025$3.65$3.79+3.84%$3.83$3.731,227 shs$189.50 million07/11/2025$3.75$3.65-2.67%$3.78$3.565,487 shs$182.50 million07/10/2025$3.71$3.75+1.19%$3.80$3.445,758 shs$187.51 million07/09/2025$3.68$3.71+0.71%$3.81$3.80694 shs$185.30 million Related Companies Nuvation Bio Stock Price Chart uniQure Stock Price Chart Pharming Group Stock Price Chart Cronos Group Stock Price Chart Sionna Therapeutics Stock Price Chart AnaptysBio Stock Price Chart GH Research Stock Price Chart Ginkgo Bioworks Stock Price Chart Niagen Bioscience Stock Price Chart Tango Therapeutics Stock Price Chart Receive GNFT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GENFIT and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GNFT) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredChina's 500 Million Year AdvantageThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENFIT S.A. Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share GENFIT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
